Viewing Study NCT03752333


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-01-04 @ 11:29 PM
Study NCT ID: NCT03752333
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-12-06
First Post: 2018-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Pembrolizumab in Cancer of Unknown Primary
Sponsor: Imperial College London
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module